Эндотелиальная дисфункция: клиническая и прогностическая значимость в хирургическом лечении облитерирующего атеросклероза брюшной аорты и артерий конечностей
Несмотря на значительный прогресс в оперативном лечении окклюзионных поражений аорты и артерий конечностей, многие проблемы остаются не разрешенными. Хотя имеются сообщения о достаточно благоприятных результатах реваскуляризирующих операций при ОАСПА, по данным которых 5-ти летняя проходимость после бедренно-подколенных реконструкций в целом составляет около 70%, на результаты восстановительных… Читать ещё >
Содержание
- ГЛАВА 1. Современные представления о функциях эндотелия, роли их нарушений в атерогенезе, в том числе — в формировании клинических проявлений облитерирующего атеросклероза (обзор литературы)
- 1. 1. Гипотеза ответа на повреждение
- 1. 2. Нормальные функции эндотелия: современные 34 представления
- 1. 3. Эндотелиальная дисфункция: клиническая диагностика, 47 принципиальная обратимость, системный характер
1. 4. Современные исследования, подтверждающие роль эндотелиальной дисфункции в развитии атеросклероза 1. 5. Клиническая и прогностическая значимость эндотелиальной дисфункции при атеросклерозе коронарных и церебральных сосудов
1. 6. Дисфункция эндотелия: клиническая и прогностическая 63 значимость при
ОАСПА
ГЛАВА 2. Методы исследования и клиническая характеристика обследованных больных
2. 1. Методы исследования 71 2. 2. Клиническая характеристика обследованных пациентов
ГЛАВА 3. Состояние функции эндотелия и системы гемостаза 92 у больных ОАСПА
Список литературы
- Айданов В.Г. Исследование функции эндотелия при комплексном подходе в лечении окклюзионных поражений артерий нижних конечностей /В.Г. Айданов //Ангиология и сосудистая хирургия. — 2003. № 3. — Приложение. — С. 6−7.
- Аронов, Д.М. Лечение и профилактика атеросклероза /Д.М. Аронов. -М.: Триада -X, 2000. 410 с.
- Бокерия Л.А. Сердечно-сосудистая хирургия 2003. Болезни и врожденные аномалии системы кровообращения /Л.А. Бокерия, Р. Г. Гудкова. — М.: Изд-во НЦССХ им. А. Н. Бакулева РАМН, 2004. — 110 с.
- Гомазков О.А. Эндотелин-превращающий фермент: функциональный план /О.А. Гомазков //Биохимия. 1998. — Том 63. — № 2. — С. 156 -164.
- Гомазков О.А. Система эндотелиновых пептидов: механизмы кардиоваскулярных патологий /О.А. Гомазков //Вопросы медицинской химии. 1999. — № 4. — С. 290 -303.
- Евдокимов, Б.Н. Ушаков- Гос. науч.-исслед. испыт. ин-т воен. медицины МО РФ.
- Нагорнев В. Атерогенез: аспекты патобиологии /В. Нагорнев, В. Анестиади, Е. Зота. СПб.: Б.и., 2001. — 330 с.
- Смертность населения Российской Федерации. 1998 г. (статистические материалы). М.: Минздрав РФ, 1999.
- Стенка сосудов в атеро- и тромбогенезе (исследования в СССР) /Под ред. Е. И. Чазова и В. Н. Смирнова. М. Медицина, 1983. — 208 с.
- L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice /W. Aji, S. Ravalli, M. Szabolcs, et al. //Circulation. 1997. — Vol. 95. — № 2. — P. 430−437.
- Anderson T.J. Assessment and treatment of endothelial dysfunction in humans /T.J. Anderson //J. Am. Coll. Cardiol. 1999. -Vol. 34. — № 3. — P. 631−638.
- Systemic nature of endothelial dysfunction in atherosclerosis /T.J. Anderson, M.D. Gerhard, I.T. Meredith, et al. //Am. J. Cardiol. 1995a. -Vol. 75. -№ 6. — P. 71B-74B.
- Close relation of endothelial function in the human coronary and peripheral circulations /T.J. Anderson, A. Uehata, M.D. Gerhard, et al. //J. Am. Coll. Cardiol. 1995b. — Vol. 26. -№ 5. — P. 1235−1241.
- Atkov O.Y. Non-invasive ultrasound detection of endothelial dysfunction /O.Y. Atkov, T.V.Balahonova, O.A. Pogorelova //Eur. J. Ultrasound. -1998.-Vol. 7. -№ 1. P. 37−45.
- Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study /D. Bainton, P. Sweetnam, I. Baker, P. Elwood //Br. Heart. J. 1994. — Vol. 72. — № 2. -P. 128−132.
- Beckman J.S. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly /J.S. Beckman, W.H. Koppenol //Am. J. Physiol. 1996. -Vol. 271. — № 5. — Pt. 1. — P. C1424-C1437.
- Bhagat K. Flow associated or flow mediated dilatation? More than just semantics /К. Bhagat, A. Hingorani, P. Vallance //Heart. 1997. — Vol. 78. — № 1. — P. 7−8. Erratum in: Heart. — 1997. -Vol. 78.-№ 4.-P. 422.
- Blann A.D. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis /A.D. Blann, C.N. McCollum //Thrombosis and Haemostasis. 1994. — Vol. 72. -№ 1. — P. 151−154.
- Von Willebrand factor, soluble P-selectin, tissue plasminogen activator inhibitor in atherosclerosis /A.D. Blann, M. Dobrotova, P. Kubisz, C.N. McCollum //Thrombosis and Haemostasis. 1995. — Vol. 74. — № 2. — P. 626−630.
- Relationship between endothelial cell markers and arterial stenosis in peripheral and carotid artery disease /A.D. Blann, A. Farrell, A. Picton, C.N. McCollum //Thromb. Res. 2000. — Vol. 97. — № 4. — P. 209−216.
- L-arginine induces nitric oxide-dependent vasodilation in patients with critical limb ischemia. A randomized, controlled study/ S.M. Bode-Boger, R.H. Boger, H. Alfke, et al. //Circulation. 1996. — Vol. 93. — № 1. — P. 8590.
- Vasoreactivity of the culprit lesion in unstable angina /Р. Bogaty, D. Hackett, G. Davies, A. Maseri //Circulation. 1994. — Vol. 90. — № 1. — P. 5−11.
- Bonetti P.O. Endothelial dysfunction: a marker of atherosclerotic risk /P.O. Bonetti, L.O. Lerman, A. Lerman //Arterioscler. Thromb. Vase. Biol. 2003. — Vol. 23. — № 2. — P. 168−175.
- Epidemiology of intermittent claudication in middle-aged men /S.J. Bowlin, J.H. Medalie, S.A. Flocke, et al. //Am. J. Epidemiol. 1994. — Vol. 140.- № 5. -P. 4184−30.
- Braman R.S. Nanogram nitrite and nitrate determination in environmental and biological materials by vanadium (III) reduction with chemiluminescence detection /R.S. Braman, S.A. Hendrix //Anal. Chem. — 1989. Vol. 61. -№ 24. — P. 2715−2718.
- Endothelial function, adhesion molecules, and inflammatory status in symptomatic and symptomatic peripheral arterial disease (Abstr.) /G. Brevetti, A. Silvestro, T. De Cristofaro, et al. //J. Am. Coll. Cardiol. 2002. — Vol. 39. — Suppl. 1. — P. 206A.
- Brown A.A. Dietary modulation of endothelial function: implications for cardiovascular disease /А.А. Brown, F.B. Hu //Am. J. Clin. Nutr. 2001. -Vol. 73.-№ 4.-P. 673−686.
- Busse R. Endothelial dysfunction in atherosclerosis /R. Busse, I. Fleming //J. Vase. Res. 1996. — Vol. 33. -№ 3. — P. 181−194.
- Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia /R.H. Boger, S.M. Bode-Boger, A. Szuba, et al. //Circulation. 1998a. — Vol. 98. — № 18. — P. 18 421 847.
- Boger R.H. Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases /R.H. Boger, S.M. Bode-Boger //Semin. Thromb. Hemost. 2000b. — Vol. 26. — № 5. -P.539−545.
- Cai H. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress /Н. Cai, D.G. Harrison //Circ. Res. 2000. — Vol. 87. — № 10. -P. 840−844.
- Calver A. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes /А. Calver, J. Collier, P. Vallance //J. Clin. Invest. 1992. — Vol. 90. — № 6. — P. 25 482 554.
- Cannon R.O. 3rd. Role of nitric oxide in cardiovascular disease: focus on the endothelium /R.O. Cannon 3rd. //Clin. Chem. 1998. — Vol. 44. — № 8(B).-P. 1809−1819.
- Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction /D.S. Celermajer, K.E. Sorensen, C. Bull, et al. //J. Am. Coll. Cardiol. 1994a. -Vol. 24. -№ 6. — P. 1468−1474.
- Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women /D.S. Celermajer, K.E. Sorensen, D.J. Spiegelhalter, et al. //J. Am. Coll. Cardiol. 1994b. — Vol. 24. — № 2. -P. 471476.
- Celermajer D.S. Endothelial dysfunction: does it matter? Is it reversible? /D.S.Celermajer //J. Am. Coll. Cardiol. 1997. — Vol. 30. — № 2. — P. 325 333.
- Celermajer D.S. Testing endothelial function using ultrasound /D.S. Celermajer //J. Cardiovasc. Pharm. 1998. — Vol. 32. — Suppl. 3. — P. S29-S32.
- Endothelial cells in physiology and in the pathophysiology of vascular disorders /D.B. Cines, E.S. Pollak, C.A. Buck, et al. //Blood. 1998. — Vol. 91. -№ 10.-P. 3527−3561.
- Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit /J.P. Cooke, A.H. Singer, P. Tsao, et al. //J. Clin. Invest. 1992. — Vol. 90. -№ 3. — P. 1168−1172.
- Cooke J.P. Is NO an endogenous antiatherogenic molecule? /J.P.Cooke, P. S. Tsao // Arterioscler. Thromb. 1994. — Vol. 14. — № 5. — P. 653−655.
- Cooke J.P. Nitric oxide synthase: role in the genesis of vascular disease /J.P.Cooke, V.J. Dzau //Annu. Rev. Med. 1997. — Vol. 48. — P. 489−509.
- Cooke J.P. Does ADMA cause endothelial dysfunction? /J.P.Cooke //Arterioscler. Thromb. Vase. Biol. 2000a. — Vol. 20. — № 9. — P. 20 322 037.
- Cooke J. P, The endothelium: a new target for therapy /J.P.Cooke //Vase. Med. 2000b. — Vol. 5. — № 1. — P. 49−53.
- Cooke J.P. Flow, NO, and atherogenesis /J.P.Cooke //Proc. Natl. Acad. Sci. USA.- 2003. Vol. 100. — № 3. — P. 768−770.
- Corretti M.C. Technical aspects of evaluating brachial artery vasodilatation using high-frequency ultrasound /M.C.Corretti, G.D. Plotnick, R.A. Vogel //Am. J. Physiol. 1995. — Vol. 268. — № 4. — Pt 2. — P. H1397-H1404.
- L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans /М.А. Creager, S.J. Gallagher, X.J. Girerd, et al. //J. Clin. Invest. 1992. — Vol. 90. — № 4. — P. 1248−1253.
- Mortality over a period of 10 years in patients with peripheral arterial disease /М.Н. Criqui, R.D. Langer, A. Fronek, et al. //N. Engl. J. Med. -1992. Vol. 326. — № 6. — P. 381−386.
- Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve /J. Czernin, R.J. Barnard, K.T. Sun, et al. //Circulation. 1995. — Vol. 92. — № 2. — P. 197−204.
- Intermittent claudication in Quebec men from 1974−1986: the Quebec Cardiovascular Study /G.R. Dagenais, S. Maurice, N.M. Robitaille, et al. //Clin. Invest. Med. 1991. — Vol. 14. -№ 2. — P. 93−100.
- Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction /N. Dakak, S. Husain, D. Mulcahy, et al. //Hypertension. -1998.-Vol. 32.-№ l.-P. 9−15.
- Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease: is there a link? /J.Danesh, R. Collins, R. Peto //Lancet. — 1997. -Vol. 350. -№ 9075. P. 430136.
- Davies P.F. Flow-mediated endothelial mechanotransduction /P.F. Davies //Physiol. Rev. 1995. — Vol. 75. -№ 3. — P. 519−560.
- Intermittent claudication: epidemiology and natural history /G. De Backer, M. Kornitzer, J. Sobolski, H. Denolin //Acta Cardiol. 1979. — Vol. 34. -№ 3. — P. 115−124.
- Antioxidants and atherosclerotic heart disease /M.N. Diaz, B. Frei, J.A. Vita, J.F. Keaney Jr//N. Engl. J. Med. 1997. — Vol. 337. — № 6. — P. 408 416.
- Dinh Xuan A.T. Non-prostanoid endothelium-derived vasoactive factors /А.Т. Dinh Xuan, T.W. Higenbottam //J. Int. Med. Res. 1989. — Vol. 17. -№ 4.-P. 305−315.
- Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity /J.W. Doucette, P.D. Corl, H.M. Payne, et al. //Circulation. 1992. — Vol. 85. — № 5. — P. 1899−1911.
- Comparison of nitroglycerin lingual spray and sublingual tablet on time of onset and duration of brachial artery vasodilation in normal subjects /А. Ducharme, J. Dupuis, S. McNicoll, et al. //Am. J. Cardiol. 1999. — Vol. 84. — № 8. — P. 952−954.
- Duncan L.E. /L.E. Duncan //Evolution of Atherosclerotic Plaque /Ed. by R. J. Jones. Chicago: University of Chicago Press, 1963.
- Comparison of peripheral endothelial dysfunction and intimal media thickness in patients with suspected coronary artery disease /M.D. Enderle, S. Schroeder, R. Ossen, et al. //Heart. 1998. — Vol. 80. — № 4. — P. 349 354.
- Esmon C.T. Molecular events that control the protein С anticoagulant pathway /С.Т. Esmon // Thromb. Haemost. 1993. — Vol. 70. — № 1. — p. 29−35.
- Feigin V.L. Systemic inflammation, endothelial dysfunction, dietary fatty acids and micronutrients as risk factors for stroke: a selective review /V.L. Feigin, C.S. Anderson, C.N. Mhurchu //Cerebrovasc. Dis. 2002. — Vol. 13.-№ 4.-P. 219−224.
- Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population /F.G. Fowkes, E. Housley, E.H. Cawood, et al. //Int. J. Epidemiol. 1991. — Vol. 20. — № 2. -P. 384−392.
- French J.E. Atherosclerosis in relation to the structure and function of the arterial intima, with special reference to th endothelium /J.E. French //Int. Rev. Exp. Pathol. 1966. — Vol. 5. — P. 253−353.
- Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin /J.E. Gage, O.M. Hess, T. Murakami, et al. //Circulation. 1986. — Vol. 73. — № 5.-P. 865−876.
- Gilligan D.M. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women /D.M. Gilligan, A.A. Quyyumi, R.O. Cannon 3rd. //Circulation. 1994. — Vol. 89. — № 6. — P. 2545−2551.
- Endothelial dysfunction, hemodynamic forces, and atherogenesis /М.А. Gimbrone Jr, J.N. Topper, T. Nagel, et al. //Ann. N. Y. Acad. Sci. 2000. -Vol. 902.-P. 230−239-
- L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits /X.J. Girerd, A.T. Hirsch, J.P. Cooke, et al. //Circ. Res. 1990. -Vol. 67. -№ 6. — P. 1301−1308.
- Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study /N. Gokce, J.F. Keaney Jr, L.M. Hunter, et al. //Circulation. 2002. — Vol. 105. — № 13. -P. 1567−1572.
- Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise /J.B. Gordon, P. Ganz, E.G. Nabel, et al. //J. Clin. Invest. 1989. — Vol. 83. — № 6. — P. 1946−1952.
- Griendling K.K. Oxidative stress and cardiovascular disease /К.К. Griendling, R.W. Alexander //Circulation. 1997. — Vol. 96. — № 10. — P. 3264−3265.
- Prognostic value of coronary vascular endothelial dysfunction /J.P. Halcox, W.H. Schenke, G. Zalos, et al. //Circulation. 2002. — Vol. 106. -№ 6.-P. 653−658.
- Evaluation of the coagulation and fibrinolytic systems in men with intermittent claudication /К. Handa, M. Takao, J. Nomoto, et al. //Angiology. 1996. — Vol. 47. — № 6. — P. 543−548.
- Handin R.I. Molecular and cellular biology of von Willebrand factor /R.I. Handin, D.D. Wagner //Prog. Hemost. Thromb. 1989. — Vol. 9. — P. 233−259.
- Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue /D.R. Harder, A.R. Lange, D. Gebremedhin, et al. //J. Vase. Res. 1997. — Vol. 34. -№ 3. — P. 237−243.
- Haust M.D. /M.D. Haust //Atherosclerosis: Proceedings of the Second International Symposium /Ed. by R.J. Jones. New-York: Springster-Verlag, 1970.-P. 12−20.
- Huo Y. Adhesion molecules and atherogenesis /Y. Huo, K. Ley //Acta Physiol. Scand. 2001. — Vol. 173. — № 1. — P. 35−43.
- Aspirin improves endothelial dysfunction in atherosclerosis /S. Husain, N.P. Andrews, D. Mulcahy, et al. //Circulation. 1998. — Vol. 97. -№ 8.-P. 716−720.
- The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes /А. Inoue, M. Yanagisawa, S. Kimura, et al. //Proc. Natl. Acad. Sci. USA.— 1989. Vol. 86. — № 8. — P. 2863−2867.
- Endothelium determines flow-dependent dilation of the epicardial coronary artery in dogs /Т. Inoue, H. Tomoike, K. Hisano, M. Nakamura //J. Am. Coll. Cardiol.-1988.-Vol. 11.-№ 1.-P. 187−191.
- Comparison of endothelial function evaluated by strain gauge plethysmography and brachial artery ultrasound /С. Irace, R. Ceravolo, L. Notarangelo, et al. //Atherosclerosis. 2001. — Vol. 158. — № 1. — P. 53−59.
- Joannides R. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo /R. Joannides //Circulation. — 1995. Vol. 91. -№ 5. -P. 1314−1319.
- Role of nitric oxide in the regulation of the mechanical properties of peripheral conduit arteries in humans /R. Joannides, V. Richard, W.E. Haefeli, et al. //Hypertension. 1997. — Vol. 30. — № 6. — P. 1465−1470.
- Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus /М.Т. Johnstone, S.J. Creager, K.M. Scales, et al. //Circulation. 1993. — Vol. 88. — № 6. — P. 2510−2516.
- Late mortality and morbidity after arterial reconstruction: the influence of arteriosclerosis in popliteal artery trifurcation /K.S. Kallero, D. Bergqvist, C. Cederholm, et al. //J. Vase. Surg. 1985. — Vol. 2. — № 4. — P. 541−546.
- Relation of vasodilator response of the brachial artery to inflammatory markers in patients with coronary artery disease /S.M. Kang, v N. Chung, J.Y. Kim, et al. //Echocardiography. 2002. — Vol. 19. — № 8. -P. 661−667.
- Kannel W.B. The Framingham Study. Cigarettes and the development of intermittent claudication /W.B. Kannel, D. Shurtleff //Geriatrics. 1973. -Vol. 28.- № 2. -P. 61−68.
- Kannel W.B. The demographics of claudication and the aging of the American population /W.B. Kannel //Vase. Med. 1996. — Vol. 1. — № 1. -P. 60−64.
- Endothelial dysfunction in hypercholesterolemia is improved by L-arginine administration: possible role of oxidative stress /Н. Kawano, T. Motoyama, N. Hirai, et al. //Atherosclerosis. 2002. — Vol. 161. — № 2. — P. 375−380.
- Lipid-lowering and skin vascular responses in patients with hypercholesterolaemia and peripheral arterial obstructive disease /F. Khan, S.J. Litchfield, P.A. Stonebridge, J.J. Belch //Vase. Med. 1999. — Vol. 4. -№ 4.-P. 233−238.
- Kristova V., Kriska M. Endothelial diseases and endothelium-protective agents /V. Kristova, M. Kriska //Bratisl. Lek. Listy. 1998. — Vol. 99.-№ 10.-P. 511−517.
- Kuvin J.T. Clinical utility of endothelial function testing: ready for prime time? /J.T. Kuvin, R.H. Karas //Circulation. 2003. — Vol. 107. — № 25.-P. 3243−3247.
- Lassila R. Peripheral arterial disease natural outcome /R. Lassila, M. Lepantalo, O. Lindfors //Acta Med. Scand. — 1986. — Vol. 220. — № 4. -P. 295−301.
- Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans /D.C. Lefroy, T. Crake, N.G. Uren, et al. //Circulation. 1993. — Vol. 88. — № 1. — P. 43−54.
- Endothelin in Coronary Endothelial Dysfunction and Early Atherosclerosis in Humans /А. Lerman, D.R. Holmes Jr, M.R. Bell, et al. //Circulation. 1995. — Vol. 92. — № 9. — P. 2426−2431.
- Leung W.H. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients /W.H. Leung, C.P. Lau, C.K. Wong //Lancet. 1993. — Vol. 341. -№ 8859.-P. 1496−1500.
- Differential impairment of vasodilator responsiveness of peripheral resistance and conduit vessels in humans with atherosclerosis Я.К. Liao, M.A. Bettmann, T. Sandor, et al. //Circ. Res. 1991. — Vol. 68. — № 4. — P. 1027−1034.
- Libby P. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research /Р. Libby, D. Egan, S. Skarlatos //Circulation. 1997. — Vol. 96. — № 11. — P. 40 954 103.
- Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women /Е.Н. Lieberman, M.D. Gerhard, A. Uehata, etal. //Ann. Intern. Med. 1994. — Vol. 121. -№ 12. — P. 936−941.
- Flow-induced vasodilation of the human brachial artery is impaired in patients < 40 years of age with coronary artery disease /Е.Н. Lieberman, M.D. Gerhard, A. Uehata, et al. //Am. J. Cardiol. 1996. — Vol. 78. — № 11. -P. 1210−1214.
- Lip G.Y. von Willebrand factor and its relevance to cardiovascular disorders /G.Y. Lip, A.D. Blann //Br. Heart J. 1995. — Vol. 74. — № 6. — P. 580−583.
- Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries /P.L. Ludmer, A.P. Selwyn, T.L. Shook, et al. //N. Engl. J. Med. 1986. — Vol. 315. — № 17. — P. 1046−1051.
- Ltischer Т. F. The endothelium as a regulator of vascular tone and growth /Т. F. Ltischer, G. Noll //The endothelium in cardiovascular disease / Ed. by T.F. Luscher. New York: Springer-Verlag, 1995. — P. 1−24.
- Management of peripheral arterial disease (PAD). TransAtlantic Inter-Society Consensus (TASC)/TASC Working Group //Eur. J. Vase. Endovasc. Surg. 2000. — Vol. 19. — № 6. — Suppl. A. — P. S1-S250.
- Plasma endothelin-1 levels in patients with peripheral arterial occlusive disease at different Fontaine’s stages /R.A. Mangiafico, L.S. Malatino, M. Santonocito, et al. //Panminerva Med. 1999. — Vol. 41. — № l.-P. 22−26.
- Treadmill exercise-induced release of endothelin-1 in patients with peripheral arterial occlusive disease at Fontaine stage lib /R.A. Mangiafico, L.S. Malatino, R.S. Spada, et al. //International Angiology. 2000. — Vol. 19.-№ l.-P. 14−17.
- Inhibition of platelet function by an aspirin-insensitive endothelial cell AD-Pase /А.J. Marcus, L. B. Safier, K. A. Hajjar et al. //J. Clin. Invest. 1991. — Vol. 88. -№ 5. — P. 1690−1696.
- Endothelial dysfunction in hypercholesterolemia is reversed by a nutritional product designed to enhance nitric oxide activity /A.J. Maxwell, B. Anderson, M.P. Zapien, J.P. Cooke //Cardiovasc. Drugs Ther. 2000a. -Vol. 14. -№ 3. — P. 309−316.
- Maxwell A.J. Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar /A.J. Maxwell, B.E. Anderson, J.P. Cooke //Vascular Medicine. 2000b. — Vol. 5.-№ l.-P. 11−19.
- Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms /М.М. McDermott, K. Liu, P. Greenland, et al. //JAMA. 2004. — Vol. 292. — № 4. — P. 453−461.
- McGorisk G.M. Endothelial dysfunction in coronary heart disease /G.M. McGorisk, C.B. Treasure //Curr. Opin. Cardiol. 1996. — Vol. 11. -№ 4.-P. 341−350.
- Early evidence of endothelial vasodilator dysfunction at coronary branch points /J.M. McLenachan, J. Vita, D.R. Fish, et al. //Circulation.1990. Vol. 82. — № 4. — P. 1169−1173.
- Meydani M. Soluble adhesion molecules: surrogate markers of cardiovascular disease? /М. Meydani //Nutr. Rev. 2003. — Vol. 61. — № 2. -P. 63−68.
- Flow-induced dilation of human coronary arterioles: important role of Ca (2+)-activated K (+) channels /Н. Miura, R.E. Wachtel, Y. Liu, et al. //Circulation.-2001.-Vol. 103. -№ 15.-P. 1992−1998.
- Mombouli J.V. Endothelium-derived hyperpolarizing factor (s): updating the unknown /J.V. Mombouli, P.M. Vanhoutte //Trends Pharmacol. Sci. 1997. — Vol. 18. -№ 7. — P. 252−256.
- Moncada S. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin /S. Moncada, J.R. Vane //Pharmacol. Rev. 1978. — Vol. 30. — № 3. — P. 293−331.
- Inhibition of injury induced thromboatherosclerotic lesions by antiplatelet serum in rabbits /S. Moore, R.J. Friedman, D.P. Singal, et al. //Thromb. Haemost. 1976. — Vol. 35. — № 1. — P. 70−81.
- Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms /W. Motz, M. Vogt, O. Rabenau, et al. //Am. J. Cardiol. 1991. — Vol. 68. — № 10. -P.996−1003.
- Murakami T. Clinical morbidities in subjects with Doppler — evaluated endothelial dysfunction of coronary artery (Abstract 1165−64) /Т. Murakami, S. Mizuno, B. Kaku 111. Am. Coll. Cardiol. 1998. — Vol. 31. -Suppl. 1.-P.419A
- The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture /М. Navab, J.A. Berliner, A.D. Watson, et al. //Arterioscler. Thromb. Vase. Biol. 1996. — Vol. 16. — № 7. — P. 831−842.
- Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease /S. Nityanand, C. Bergmark, U. de Faire et al. //Journal of Internal Medicine. 1995. — Vol. 238. — № 5. — P. 437−443.
- Prevalence of risk factors in patients with peripheral arterial disease. A clinical and epidemiological evaluation /S. Novo, G. Avellone, V. Di Garbo, et al. //Int. Angiol. 1992. — Vol. .11. — № 3. — P. 218−229.
- Ohara Y. Hypercholesterolemia increases endothelial superoxide anion production /Y. Ohara, Т.Е. Peterson, D.G. Harrison //J. Clin. Invest. -1993. Vol. 91. — № 6. — P. 2546−2551.
- Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade /М. Ohno, J.P. Cooke, V.J. Dzau, G.H. Gibbons //J. Clin. Invest. -1995. Vol. 95. -№ 3. -P. 1363−1369.
- Trading-off longer life for worsening health: the expansion of morbidity hypothesis /S.J. Olshansky, M.A. Rudberg, B.A. Carnes, et al. //J. Health Age. 1991. — Vol. 3. — P. 194−216.
- Palmer R.M. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor /R.M. Palmer, A.G. Ferrige, S. Moncada //Nature. 1987. — Vol. 327. — № 6122. — P. 524−526.
- Palmer R.M. Vascular endothelial cells synthesize nitric oxide from L-arginine /R.M. Palmer, D.S. Ashton, S. Moncada //Nature. 1988. — Vol. 333. -№ 6174. — P. 664−666.
- Petros A. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock /А. Petros, D. Bennett, P. Vallance //Lancet. — 1991.-Vol. 338.-№ 8782−8783.-P. 1557−1558.
- Playford D.A. Special article: non-invasive measurement of endothelial function /D.A. Playford, G.F. Watts //Clin. Exp. Pharmacol. Physiol. 1998. — Vol. 25. -№ 7−8. — P. 640−643.
- Crucial role of endothelium in the vasodilator response to increased flow in vivo /U. Pohl, J. Holtz, R. Busse, E. Bassenge //Hypertension. -1986.-Vol. 8. -№ 1.-P. 37−44.
- Risk factors associated with the development of peripheral arterial disease in smokers: a case-control study /J.T. Powell, R.J. Edwards, P.C. Worrell, et al. //Atherosclerosis. 1997. — Vol. 129. — № 1. — P. 41−48.
- Effect of ascorbic acid on forearm reactive hyperaemia in patients with hypercholesterolaemia /A.D. Protogerou, J.P. Lekakis, D.D. Kontoyanni, et al. //Eur. J. Cardiovasc. Prev. Rehabil. 2004. — Vol. 11.-№ 2. — P. 149−154.
- Contribution of nitric oxide to metabolic coronary vasodilation in the human heart /А.А. Quyyumi, N. Dakak, N.P. Andrews, et al. //Circulation. 1995. — Vol. 92. — № 3. — P. 320−326.
- Quyyumi A.A. Prognostic value of endothelial function /А.А. Quyyumi //Am. J. Cardiol. 2003. — Vol. 91. — Suppl. — P. 19H-24H.
- Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults /О.Т. Raitakari, M.R. Adams, R.J. McCredie, et al. //Ann. Intern. Med. 1999. — Vol. 130. — № 7. — P. 578−581.
- Raitakari O.T. Testing for endothelial dysfunction /О.Т. Raitakari, D.S. Celermajer //Ann. Med. 2000a. — Vol. 32. — № 5. — P. 293−304.
- Raitakari O.T. Flow-mediated dilatation /О.Т. Raitakari, D.S. Celermajer //Br. J. Clin. Pharmacol. 2000b. — Vol. 50. — № 5. — P. 397 404.
- Rappaport S.I. Initiation and regulation of tissue factor dependent blood coagulation /S.I. Rappaport, L.V. Rao //Arterioscler. Thromb. — 1992. -Vol. 12. -№ 10.-P. 1111−1121.
- Endogenous tissue-type plasminogen activator and risk of myocardial infarction /P.M. Ridker, D.E. Vaughan, M.J. Stampfer, et al. //Lancet. — 1993. Vol. 341. — № 8854. — P. 1165−1168.
- Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis /L.E. Rohde, R.T. Lee, J. Rivero, et al. //Arterioscler. Thromb. Vase. Biol. 1998. — Vol. 18. — № 11. -P. 1765−1770.
- Rosenberg R.D. The heparine-antythrombin system: a natural anticoagulant mechanism /R.D. Rosenberg, K.A. Bauer //Hemostasis and Thrombosis /Ed. by R.W. Coleman, J. Hirsch, V.J. Marder, E. W Salmon. -Philadelphia, PA: Lippincott, 1994. P. 837−860.
- Rosenson R.S. Antiatherothrombotic effects of nicotinic acid /R.S. Rosenson //Atherosclerosis. 2003. — Vol. 171. — № 1. — P. 87−96.
- Ross R. Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis /R. Ross, J.A. Glomset //Science. 1973. — Vol. 180. — № 93.-P. 1332−1339.
- Ross R. The pathogenesis of atherosclerosis (first of two parts) /R. Ross, J.A. Glomset //N. Engl. J. Med. 1976a. — Vol. 295. — № 7. — P. 369 377.
- Ross R. The pathogenesis of atherosclerosis (second of two parts) /R. Ross, J.A. Glomset //N. Engl. J. Med. 1976b. — Vol. 295. — № 8. — P. 420 425.
- Ross R. The pathogenesis of atherosclerosis an update /R. Ross //N. Engl. J. Med. — 1986. — Vol. 314. — № 8. — P. 488−500.
- Ross R. Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry /R. Ross //Am. J. Pathol. 1993a. — Vol. 143. — № 4. -P. 1987−1002.
- Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s /R. Ross //Nature. 1993b. — Vol. 362. — № 6423. — P. 801−809.
- Ross R. Atherosclerosis an inflammatory disease /R. Ross //N. Engl. J. Med. — 1999. — Vol. 340. -№ 2. — P. 115−126.
- Rubanyi G.M. Flow-induced release of endothelium-derived relaxing factor /G.M.Rubanyi, J.C. Romero, P.M. Vanhoutte //Am. J. Physiol. -1986. Vol. 250. — № 6. — Pt 2. — P. HI 145-H1149.
- Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study /V. Salomaa, V. Stinson, J.D. Kark, et al. //Circulation. 1995. — Vol. 91. — № 2. — P. 284 290.
- Schachinger V. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease /V. Schachinger, M.B. Britten, A. M Zeiher. //Circulation. 2000. — Vol. 101. -№ 16.-P. 1899−1906.
- Schwartz S.M. Aortic endothelial cell replication. I. Effects of age and hypertension in the rat /S.M. Schwartz, E.P. Benditt //Circ. Res. -1977. Vol. 41. — № 2. — P. 248−255.
- Relation of inflammation to vascular function in patients with coronary heart disease /J. Sinisalo, J. Paronen, K.J. Mattila, et al. //Atherosclerosis. 2000. — Vol. 149. — № 2. — P. 403111.
- Characteristics of flow-mediated brachial artery vasodilation in human subjects /L.I. Sinoway, C. Hendrickson, W.R. Davidson Jr, et al. //Circ. Res. 1989. — Vol. 64. -№ 1. — P. 32−42.
- Smith E.B. Relationship between low-density lipoprotein in aortic intima and serum-lipid levels /Е.В. Smith, R.S. Slater //Lancet. — 1972. — Vol. 1. № 7748. — P. 463−469.
- Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease /F.B. Smith, G.D. Lowe, F.G. Fowkes, et al. //Atherosclerosis. 1993. — Vol. 102. — № 2. — P. 155−162.
- Complexing of serum pre-beta and beta-lipoproteins and acid mucopolysaccharides /S.R. Srinivasan, A. Lopez, B. Radhakrishnamurthy, G.S. Berenson //Atherosclerosis. 1970. — Vol. 12. — № 3. — P. 321−334.
- Stampfer M.J. Can lowering homocysteine levels reduce cardiovascular risk? /M.J. Stampfer, M.R. Malinow //N. Engl. J. Med. -1995. Vol. 332. — № 5. — P. 328−329.
- Stoffers H.E.J.H. Intermittent claudication in Scotland /H.E.J.H. Stoffers, M. Woodward, H. Tunstall-Pedoe //Epidemiology of peripheral vascular disease /Ed. by F.G.R Fowkes. London: Springer-Verlag, 1991. — P. 109−115.
- Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction /J.A. Suwaidi, S. Hamasaki, S.T. Higano, et al. //Circulation. 2000. — Vol. 101. — № 9. — P. 948−954.
- Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease /В. Takase, A. Uehata, T. Akima, et al. //Am. J. Cardiol. 1998. — Vol. 82. — № 12. — P. 15 351 539, A7−8.
- Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events /P.V. Targonski, P.O. Bonetti, G.M. Pumper, et al. //Circulation. 2003. — Vol. 107. — № 22. — P. 2805−2809.
- Thompson E.A. Inhibition by human thrombomodulin of factor Xa-mediated cleavage of prothrombin /Е.А. Thompson, H.H. Salem //J. Clin. Invest. 1986. — Vol. 78. -№ 1. — P. 13−17.
- Topper J.N. Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype /J.N. Topper, M.A. Gimbrone Jr. //Mol. Med. Today. 1999. — Vol. 5. — № 1. — P. 40−46.
- Toutouzas P.C. Nitric oxide synthesis in atherosclerosis /Р.С. Toutouzas, D. Tousoulis, G.J. Davies //Eur. Heart. J. 1998. — Vol. 19. — № 10.-P. 1504−1511.
- Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels /С.В. Treasure, J.L. Klein, J.A. Vita, et al. //Circulation. 1993. -Vol. 87.-№ l.-p. 86−93.
- Evidence for the involvement of endothelin-1 but not urotensin-II in chronic lower limb ischaemia in man /J.C. Tsui, D.M. Baker, E. Biecker, et al. //Eur. J. Vase. Endovasc. Surg. 2003. — Vol. 25. — № 5. — P. 443−450.
- Noninvasive assessment of endothelium-dependent flow-mediated dilation of the brachial artery /А. Uehata, E.H. Lieberman, M.D. Gerhard, et al. //Vase. Med. 1997. — Vol. 2. -№ 2. — P. 87−92.
- Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress /М. Uematsu, Y. Ohara, J.P. Navas, et al. //Am. J. Physiol. -1995.-Vol. 269. -№ б.-Pt l.-P. C1371-C1378.
- Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: the Rotterdam Study Я.М. Van Der Meer, M.P. De Maat, M.L. Bots, et al. //Arterioscler. Thromb. Vase Biol. 2002a. -Vol. 22. -№ 5. — P. 838−842.
- C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study /1.М. Van Der Meer, M.P. De Maat, A.E. Hak, et al. //Stroke. 2002b. — Vol. 33. — № 12. — P. 2750−2755.
- WHO. World Health Report. 2004. Geneva: WHO, 2004.
- Virchow R. Phlogose und Thrombose im Gefassystem, Gesammelte Abhandlungen zur Wissenschaftlichen Medicin /R. Virchow. Frankfurt-am-Main: Meidinger Sohn and Company, 1856. — P. 458.
- Wood D. Established and emerging cardiovascular risk factors /D. Wood //Am. Heart J. 2001. — Vol. 141. — № 2. — Suppl. — P. S49−57.
- Clinical, biochemical, and rheologic factors affecting the outcome of infrainguinal bypass grafting /K.R. Woodburn, A. Rumley, G.D. Lowe, et al. //J. Vase. Surg. 1996. — Vol. 24. — № 4. — P. 639−646.
- Woodburn K.R. Fibrinogen, fibrin turnover, endothelial products and vascular surgery /K.R. Woodburn, G.D.O. Lowe //Br. J. Surg. 1997. -Vol. 84. — № 8. — P. 1059−1064.
- Wright C.E. Protective and pathological roles of nitric oxide in endotoxin shock /С.Е. Wright, D.D. Rees, S. Moncada //Cardiovasc. Res. -1992. Vol. 26. — № 1. — P. 48−57.
- Wright H.P. Aortic endothelial mitosis and Evans blue uptake in cholesterol-fed subscorbutic guinea-pigs /Н.Р. Wright, M. Evans, R.P. Green //Atherosclerosis. 1975. — Vol. 21. — № 1. — P. 105−113.
- Wu K.K. Role of endothelium in thrombosis and hemostasis /К.К. Wu, P. Thiagarajan //Annu. Rev. Med. 1996. — Vol. 47. — P. 315−331.
- A novel potent vasoconstrictor peptide produced by vascular endothelial cells /М. Yanagisawa, H. Kurihara, S. Kimura, et al. //Nature. -1988.-Vol. 332.-№ 6163.- P. 411−415.
- Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease /A.R. Yataco, M.C. Corretti, A.W. Gardner, et al. //Am. J. Cardiol. 1999. — Vol. 83. — № 5. — P. 754−758.
- Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis /I. Yokoyama, T. Ohtake, S. Momomura, et al. //Circulation. 1996. — Vol. 94. — № 12. — P. 3232−3238.
- Vitamin E supplementation and cardiovascular events in high-risk. patients. The Heart Outcomes Prevention Evaluation Study Investigators /S. Yusuf, G. Dagenais, J. Pogue, et al. //N. Engl. J. Med. 2000. — Vol. 342. -№ 3. — P. 154−160.
- Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary therosclerosis /A.M. Zeiher, H. Drexler, H. Wollschlager, H. Just //Circulation. 1991. — Vol. 83. -№ 2. -P. 391−401.